ASP Isotopes Halves QLE Note Balance in Share Exchange
The transaction covered $109.2 million of convertible-note principal plus accrued interest.
ASP Isotopes (ASPI), the isotope-enrichment company, agreed to exchange QLE convertible notes for its common stock, reducing the outstanding principal by roughly half.
The deal shifted a substantial portion of QLE’s financing claim into equity, lowering the related note balance while expanding ASP Isotopes’ share count.
Under the agreement, noteholders would receive about 23.2 million ASPI shares in exchange for the principal and accrued interest.
The transaction would reduce QLE notes outstanding to $110.7 million from $219.8 million.
The shares issued in the exchange would equal about 17.8% of ASP Isotopes’ currently outstanding common stock, making dilution the principal offset to the lower note balance.
The exchange left QLE with a smaller convertible-note obligation while giving former noteholders a direct equity stake in ASP Isotopes.